TJ Biotech Holding ApS
CVR 41953616 · Private limited company (ApS) · Active · Low risk
TJ Biotech Holding ApS is a Private limited company (ApS), founded on , based in Holte. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 6 annual reports have been published, of which 6 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 18.6m and a net result of DKK 4.2m. CEO: Thomas Engelbrecht Nordkild Jonassen.
Bankruptcy risk for TJ Biotech Holding ApS
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41953616
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (5 years)
- Address
- Pile Alle 20
2840 Holte - Municipality
- Rudersdal
- Industry
- Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse - Share capital
- DKK 40k
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 6 of 6 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 77.8% |
| Current ratio | 1,228% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 70k | DKK 118k |
| Net profit | DKK 4.2m | DKK 668k |
| Equity | DKK 18.6m | DKK 14.4m |
| Total assets | DKK 23.9m | DKK 18.9m |
| Cash | DKK 216k | – |
| Short-term debt | DKK 1.1m | – |
| Tax owed | DKK 831k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 189 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 184 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 187 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 187 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 197 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Engelbrecht Nordkild Jonassen | Current | |
| Owner (100%) | Thomas Engelbrecht Nordkild Jonassen | Current | |
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB |
The CEOs' other companies
Thomas Engelbrecht Nordkild Jonassen – 14 other companies
- ACTION INFLAMMATION ApS Fusioneret
- ACTION PHARMA A/S Opløst
- ACTION PHARMA ApS Fusioneret
- ACTION PHARMA HOLDING I A/S Opløst
- BioInvest ApS Fusioneret
- NaviSurg Vision ApS Active
- Perfusion Tech ApS Active
- ResoTher Pharma A/S Active
- SELSKABET AF 20.02.2002 ApS Opløst
- SYNACT PHARMA ApS Active
- TENJ BIOTECH ApS Fusioneret
- TJ BIOTECH HOLDING ApS Fusioneret
- TJ Biotech Holding II ApS Fusioneret
- TJ Biotech Invest ApS Active
Address history (0 moves)
| Pile Alle 20, 2840 Holte |
Other companies at the same address
- TENJ BIOTECH ApS Fusioneret
- TJ BIOTECH HOLDING ApS Fusioneret
- TJ Biotech Holding II ApS Fusioneret
- TJ Biotech Invest ApS Active
Similar companies in Rudersdal
- SØLCO ApS Vedbæk
- MEDIATIONCENTER Aps Skodsborg
- K K INFORMATIK ApS Birkerød
- BURRITO A/S Vedbæk
- Clausum ApS Holte
- Rapatel ApS Vedbæk
- S.A. Group ApS Nærum
- Garage One ApS Holte
- ScaleBeyond Nordic ApS Holte
- Buhl Global Advisory ApS Virum
- Sapheo ApS Holte
- Exergy Consulting ApS Vedbæk
Questions and answers about TJ Biotech Holding ApS
Has TJ Biotech Holding ApS gone bankrupt?
No, TJ Biotech Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of TJ Biotech Holding ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of TJ Biotech Holding ApS?
Thomas Engelbrecht Nordkild Jonassen is the CEO of TJ Biotech Holding ApS.
Who is the auditor of TJ Biotech Holding ApS?
TJ Biotech Holding ApS most recently used Cedra Godkendt Revisionsaktieselskab.
When was TJ Biotech Holding ApS founded?
TJ Biotech Holding ApS was founded on 14 December 2020.
What is the equity of TJ Biotech Holding ApS?
Equity was DKK 18.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.